abstract |
The present invention provides a method of treating a subject characterized by: (i) altering a lipid parameter of a subject, (c) altering a somatic component parameter of a subject, (c) treating a disease characterized by deficient or diminished bone formation of the subject, Or GH secretagogues to improve cognitive function, to improve metabolic disease in a subject, to improve assimilation in a subject's catabolic disease, and / or to improve and / or restore the immune function of a subject (e.g., For example GRF or an analog of GRF). |